Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.52 |
| ▸ | MMP3 | P08254 | 12/20 | 0.52 |
| ▸ | QDPR | P09417 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6584985 | 0.92 | MMP2 (0.51) | MMP2MMP3QDPRPOLBALOX15 | |
| SCHEMBL6586229 | 0.91 | MMP2 (0.59) | MMP2MMP3QDPRHSD11B1 | |
| SCHEMBL6586274 | 0.91 | MMP2 (0.55) | MMP2MMP3QDPRPOLBALOX15 | |
| SCHEMBL6584515 | 0.87 | MMP2 (0.59) | MMP2MMP3QDPR | |
| SCHEMBL6587364 | 0.82 | MMP2 (0.63) | MMP2MMP3QDPRL3MBTL1KDM4E | |
| SCHEMBL6586371 | 0.82 | MMP3 (0.77) | MMP2MMP3QDPRL3MBTL1KDM4E | |
| SCHEMBL6437646 | 0.78 | MMP2 (0.48) | MMP2MMP3QDPRL3MBTL1 | |
| SCHEMBL6582915 | 0.77 | MMP2 (0.72) | MMP2MMP3 | |
| SCHEMBL6587473 | 0.77 | MMP2 (0.58) | MMP2MMP3L3MBTL1KDM4EHSD11B1 | |
| SCHEMBL6586244 | 0.76 | MMP2 (0.49) | MMP2MMP3L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |
| EP-1036062-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | Pfizer Limited (GB) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029667-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LIMITED (GB) | 1999-06-17 | — | — | WO | disclosed |